International Subarachnoid Aneurysm Trial II

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,724

Participants

Timeline

Start Date

November 12, 2012

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Intracranial Hemorrhage Ruptured Aneurysm
Interventions
PROCEDURE

surgical management

Surgical clipping will be performed as soon as possible following randomization, according to standards of practice, and under general anesthesia. Aneurysms thought by the treating physicians to require deliberate permanent proximal vessel occlusion, construction of a surgical bypass, or other flow-redirecting treatments that do not directly clip the aneurysm will not be excluded; these non-ISAT aneurysms are expected to be more difficult lesions to manage surgically as well as endovascularly.

PROCEDURE

Endovascular management

Endovascular treatment will also be performed as soon as possible following randomization,according to standards of practice, and under general anesthesia. Details regarding type of coils, use of adjunctive techniques such as balloon-remodeling, stents or flow-diverters, as well as post-treatment medical management issues, will be left up to the physician performing the endovascular treatment.

Trial Locations (6)

10467

Montefiore Medical Center, The Bronx

T2N 2T9

Foothills Medical Centre, Calgary

Unknown

University of Alberta Hospital, Edmonton

Vall d'Hebron Hospital, Barcelona

University of Valladolid, Valladolid

H2X 0C1

Centre Hospitalier de l'Université de Montréal - Hôpital Notre Dame, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT01668563 - International Subarachnoid Aneurysm Trial II | Biotech Hunter | Biotech Hunter